Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-123988
Filing Date
2025-05-21
Accepted
2025-05-21 16:15:11
Documents
23
Effectiveness Date
2025-05-21

Document Format Files

Seq Description Document Type Size
1 S-8 d111933ds8.htm S-8 68574
2 EX-5.1 d111933dex51.htm EX-5.1 8942
3 EX-23.1 d111933dex231.htm EX-23.1 2105
4 EX-99.1 d111933dex991.htm EX-99.1 62685
5 EX-99.2 d111933dex992.htm EX-99.2 159516
6 EX-99.3 d111933dex993.htm EX-99.3 34138
7 EX-99.4 d111933dex994.htm EX-99.4 30364
8 EX-99.5 d111933dex995.htm EX-99.5 36470
9 EX-99.6 d111933dex996.htm EX-99.6 36123
10 EX-99.7 d111933dex997.htm EX-99.7 60029
11 EX-99.8 d111933dex998.htm EX-99.8 59235
12 EX-FILING FEES d111933dexfilingfees.htm   iXBRL EX-FILING FEES 14115
13 GRAPHIC g111933g0519161313706.jpg GRAPHIC 2413
  Complete submission text file 0001193125-25-123988.txt   702281

Data Files

Seq Description Document Type Size
25 EXTRACTED XBRL INSTANCE DOCUMENT d111933dexfilingfees_htm.xml XML 8057
Mailing Address 6027 EDGEWOOD BEND COURT SAN DIEGO CA 92130
Business Address 6027 EDGEWOOD BEND COURT SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-287477 | Film No.: 25973311
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)